Scrip Clinical Research - Bias in drug trials leads to call for more transparency

Whether from selective reporting or other factors, clinical trials funded by pharmaceutical firms are significantly more likely to report favourable results than those funded by academia or government agencies, suggests a new study by researchers from Children's Hospital Boston.